GJA1 and mood disorder: Based on the above clinical and preclinical findings, in this review, we introduce clinical findings regarding the abnormality of Cx43 in mood disorders, and discuss the potential of Cx43 as a target of mood-stabilising medication in the pathophysiology of mood disorders associated with Cx43.